383 results
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
17 Apr 24
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
7:30am
) a decrease of $0.1 million in personnel costs due to headcount reductions; partially offset by (iv) the reversal of $0.5 million in incentive bonus
8-K
EX-2.1
cl6ib7ax
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-3.1
p1d 24rb2o1
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-99.1
fweyj7i0ufpjcyu5
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
424B5
kum93b4x
9 Nov 23
Prospectus supplement for primary offering
4:11pm
S-8
42yq0l47 b18b7z
30 Aug 23
Registration of securities for employees
4:31pm
S-8
EX-5.1
wjze467ky
30 Aug 23
Registration of securities for employees
4:31pm
S-8
EX-23.3
udpr81oh7 9bhwnm
30 Aug 23
Registration of securities for employees
4:31pm
S-8
dyri4
30 Aug 23
Registration of securities for employees
4:31pm
8-K
9xi0q
28 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
1loyvkj
16 Aug 23
Departure of Directors or Certain Officers
5:19pm